Cargando…

Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?

INTRODUCTION: Cognitive impairment is a highly prevalent non-motor feature of Parkinson’s disease (PD). A better understanding of the underlying pathophysiology may help in identifying therapeutic targets to prevent or treat dementia. This study sought to identify metabolic alterations in the prefro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buard, Isabelle, Lopez-Esquibel, Natalie, Carey, Finnuella J., Brown, Mark S., Medina, Luis D., Kronberg, Eugene, Martin, Christine S., Rogers, Sarah, Holden, Samantha K., Greher, Michael R., Kluger, Benzi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039312/ https://www.ncbi.nlm.nih.gov/pubmed/35496064 http://dx.doi.org/10.3389/fnhum.2022.809905

Ejemplares similares

Preliminary Neurophysiological Evidence of Altered Cortical Activity and Connectivity With Neurologic Music Therapy in Parkinson's Disease
por: Buard, Isabelle, et al.
Publicado: (2019)

Randomized controlled trial of neurologic music therapy in Parkinson’s disease: research rehabilitation protocols for mechanistic and clinical investigations
por: Buard, Isabelle, et al.
Publicado: (2021)

A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography
por: Simon, Olivier B., et al.
Publicado: (2021)

Altered oscillation patterns and connectivity during picture naming in autism
por: Buard, Isabelle, et al.
Publicado: (2013)

Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease
por: Carlisle, Tara C., et al.
Publicado: (2023)

Palliative care for Parkinson’s disease: suggestions from a council of patient and carepartners
por: Hall, Kirk, et al.
Publicado: (2017)

Neuromagnetic Beta-Band Oscillations during Motor Imitation in Youth with Autism
por: Buard, I., et al.
Publicado: (2018)

Prefrontal glutamate levels predict altered amygdala–prefrontal connectivity in traumatized youths
por: Ousdal, Olga Therese, et al.
Publicado: (2019)

2210: Anatomical substrates of cognitive fatigue in aging and in Parkinson’s disease
por: Burke, Sarah Elizabeth, et al.
Publicado: (2018)

Prefrontal Cortex Glutamate Correlates with Mental Perspective-Taking
por: Montag, Christiane, et al.
Publicado: (2008)

Sex differences in the medial prefrontal cortical glutamate system
por: Knouse, Melissa C., et al.
Publicado: (2022)

The elephant in the room: critical reflections on mortality rates among individuals with Parkinson’s disease
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2023)

Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women
por: Yap, Sidney, et al.
Publicado: (2021)

Prefrontal GABA and glutamate–glutamine levels affect sustained attention
por: Kondo, Hirohito M, et al.
Publicado: (2023)

Cost and Return on Investment of a Team-Based Palliative Care Program for Parkinson Disease
por: McQueen, Robert Brett, et al.
Publicado: (2022)

Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson's Disease Patients in Colorado
por: Finseth, Taylor Andrew, et al.
Publicado: (2015)

Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex
por: Kulijewicz-Nawrot, Magdalena, et al.
Publicado: (2013)

Prefrontal cortex glutamate afferents are essential for acute and chronic effects of Ritalin
por: Wanchoo, Sheshali, et al.
Publicado: (2010)

Roles of Glutamate Receptors in Parkinson’s Disease
por: Zhang, Zhu, et al.
Publicado: (2019)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Structural brain correlates of fatigue in older adults with and without Parkinson's disease
por: Kluger, Benzi M., et al.
Publicado: (2019)

Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US
por: Feeney, Megan P., et al.
Publicado: (2021)

Functional Roles of Neural Preparatory Processes in a Cued Stroop Task Revealed by Linking Electrophysiology with Behavioral Performance
por: Wang, Chao, et al.
Publicado: (2015)

Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
por: Lohith, Talakad G, et al.
Publicado: (2013)

Lower Ventromedial Prefrontal Cortex Glutamate Levels in Patients With Obsessive–Compulsive Disorder
por: Batistuzzo, Marcelo C., et al.
Publicado: (2021)

Prefrontal Physiomarkers of Anxiety and Depression in Parkinson’s Disease
por: de Hemptinne, Coralie, et al.
Publicado: (2021)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
por: Wang, Ji, et al.
Publicado: (2020)

Functional and Structural Remodeling of Glutamate Synapses in Prefrontal and Frontal Cortex Induced by Behavioral Stress
por: Musazzi, Laura, et al.
Publicado: (2015)

Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence
por: Prisciandaro, J J, et al.
Publicado: (2017)

Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
por: Schoonover, Kirsten E., et al.
Publicado: (2020)

Glutamate Carboxypeptidase II in Aging Rat Prefrontal Cortex Impairs Working Memory Performance
por: Datta, Dibyadeep, et al.
Publicado: (2021)

Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques
por: Bathla, Shveta, et al.
Publicado: (2023)

Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson’s disease
por: Carlisle, Tara C., et al.
Publicado: (2023)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

The Prevalence of Fatigue Following Deep Brain Stimulation Surgery in Parkinson's Disease and Association with Quality of Life
por: Kluger, Benzi M., et al.
Publicado: (2012)

Palliative Care in Movement Disorders: an Evolving Field
por: Macchi, Zachary A., et al.
Publicado: (2021)

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
por: Gautam, Deepa, et al.
Publicado: (2023)

Modulation of Dorsolateral Prefrontal Cortex Glutamate/Glutamine Levels Following Repetitive Transcranial Magnetic Stimulation in Young Adults With Autism
por: Moxon-Emre, Iska, et al.
Publicado: (2021)

microRNA Profiles in Parkinson's Disease Prefrontal Cortex
por: Hoss, Andrew G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aqaaunjpt3svs9gjmjdllsjhe0